透過您的圖書館登入
IP:3.149.251.155

摘要


治療復發性子宮內膜癌之方法有限,大多採姑息性化學治療或放射線治療,但效果很差。最近有文獻指出,以減積手術來治療骨盆腔或腹腔之復發性子宮內膜癌病灶,效果不錯,尤其對可以將復發病位全部切除之病例,可以得到較長時間的生存,唯需謹慎選擇患者,才能減少手術的罹病率和死亡率。

並列摘要


Treatment options for recurrent endometrial cancer are limited, Most patients with recurrent disease are treated with palliative chemotherapy or radiation therapy, and results are poor even when there is only a vaginal cuff recurrence, Traditionally, cytoreductive surgery does not have a definite role in the treatment of patients with recurrent endometrial cancer. It was unclear if maximal cytoreductive surgery could carry benefit in pelvic and abdominal recurrent endometrial carcinoma. In recent reports, cytoreductive surgery was found to have an efficacy in women with large pelvic or abdominal recurrence from endometrial cancer. Tumor can be completely resected in the majority of the patients. Complete salvage cytoreductive surgery for recurrent endometrial cancer is associated with prolonged post-recurrence survival. However, careful selection of patients is needed to minimize mobility and mortality.

延伸閱讀